Perrigo Company plc (PRGO)

IE — Healthcare Sector
Peers: RDY  PBH  COLL  XRAY  UHS  RMD  COR  HSIC 

Automate Your Wheel Strategy on PRGO

With Tiblio's Option Bot, you can configure your own wheel strategy including PRGO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol PRGO
  • Rev/Share 31.3025
  • Book/Share 32.3611
  • PB 0.724
  • Debt/Equity 0.8571
  • CurrentRatio 2.3222
  • ROIC -0.0183

 

  • MktCap 3223569690.0
  • FreeCF/Share 1.8575
  • PFCF 12.5577
  • PE -40.3241
  • Debt/Assets 0.3797
  • DivYield 0.0483
  • ROE -0.0181

 

  • Rating C+
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 5
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade PRGO Argus Buy Hold -- -- Jan. 14, 2025
Downgrade PRGO Piper Sandler Overweight Neutral $34 $27 Jan. 6, 2025
Resumed PRGO Jefferies -- Hold $50 $30 Sept. 24, 2024

News

Are Investors Undervaluing Perrigo (PRGO) Right Now?
PRGO
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Are Investors Undervaluing Perrigo (PRGO) Right Now?
International Markets and Perrigo (PRGO): A Deep Dive for Investors
PRGO
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative

Review Perrigo's (PRGO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Read More
image for news International Markets and Perrigo (PRGO): A Deep Dive for Investors
Perrigo (PRGO) Loses 16.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PRGO
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Negative

The heavy selling pressure might have exhausted for Perrigo (PRGO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Read More
image for news Perrigo (PRGO) Loses 16.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
PRGO
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive

PRGO tops Q2 EPS but misses revenue; trims 2025 sales outlook, sending shares down in pre-market.

Read More
image for news Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut
Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript
PRGO
Published: August 06, 2025 by: Seeking Alpha
Sentiment: Neutral

Perrigo Company plc (NYSE:PRGO ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations & Corporate Communications Eduardo Guarita Bezerra - Executive VP & CFO Patrick Lockwood-Taylor - President, CEO & Director Conference Call Participants Ethan Harris Brown - JPMorgan Chase & Co, Research Division Keith Jude Devas - Jefferies LLC, Research Division Susan Kay Anderson - Canaccord Genuity Corp., Research Division Operator Good morning, ladies and gentlemen. Welcome to Perrigo Q2 2025 Financial Results Conference Call.

Read More
image for news Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript
Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say
PRGO
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for Perrigo (PRGO) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news Perrigo (PRGO) Reports Q2 Earnings: What Key Metrics Have to Say
Wall Street Analysts Think Perrigo (PRGO) Could Surge 36.02%: Read This Before Placing a Bet
PRGO
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive

The mean of analysts' price targets for Perrigo (PRGO) points to a 36% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Read More
image for news Wall Street Analysts Think Perrigo (PRGO) Could Surge 36.02%: Read This Before Placing a Bet
Perrigo Announces Quarterly Dividend
PRGO
Published: July 30, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN , July 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. About Perrigo Perrigo Company plc is a leading pure-play self-care company with over a century of experience in providing high-quality health and wellness solutions to consumers primarily in North America and Europe.

Read More
image for news Perrigo Announces Quarterly Dividend
Perrigo to Report Q2 Earnings: What's in Store for the Stock?
PRGO
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Negative

PRGO eyes Q2 results, which are likely to show sales of $1.08 billion, as investors await updates on its Kairos deal and macro pressures.

Read More
image for news Perrigo to Report Q2 Earnings: What's in Store for the Stock?
Is Perrigo (PRGO) Stock Undervalued Right Now?
PRGO
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Is Perrigo (PRGO) Stock Undervalued Right Now?
Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million
KKR, PRGO
Published: July 14, 2025 by: PRNewsWire
Sentiment: Neutral

Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfront Cash and Up to €27 Million in Potential Future Milestone Payments Expected Net Proceeds to be Directed Towards Previously Announced Capital Allocation Priorities, Including Further Strengthening the Company's Balance Sheet DUBLIN , July 14, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or the "Company"), a leading global provider of Consumer Self-Care Products, today announced it has signed an agreement with Kairos Bidco AB, an investment vehicle managed by KKR, …

Read More
image for news Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million
Should Value Investors Buy Perrigo (PRGO) Stock?
PRGO
Published: July 09, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Perrigo (PRGO) Stock?
Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby
PRGO
Published: July 01, 2025 by: PRNewsWire
Sentiment: Neutral

Beginning July 1, 2025, a month-long giveaway contest will award 100 winners with two months' worth of Good Start® | Dr. Brown's™ Gentle Pro™ baby formula plus Dr. Brown's products (valued at $516.49) – and support families in need with a donation of formula to Baby2Baby that exceeds the total contest value GRAND RAPIDS, Mich. , July 1, 2025 /PRNewswire/ -- Today, the makers of Good Start® | Dr. Brown's™ infant formula announced a nationwide giveaway contest to support families across the country.

Read More
image for news Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby
Should Value Investors Buy Perrigo (PRGO) Stock?
PRGO
Published: June 23, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Should Value Investors Buy Perrigo (PRGO) Stock?
These 3 Dividend Stocks Combine Strong Yields With Upside
HAS, PRGO, XOM
Published: June 20, 2025 by: MarketBeat
Sentiment: Positive

Dividend stocks can play many roles in an investor's portfolio. Income generation is paramount.

Read More
image for news These 3 Dividend Stocks Combine Strong Yields With Upside
Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect?
PRGO
Published: June 11, 2025 by: Zacks Investment Research
Sentiment: Positive

The consensus price target hints at a 32.9% upside potential for Perrigo (PRGO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Read More
image for news Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect?
Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?
PRGO
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Negative

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock?

Read More
image for news Why Is Perrigo (PRGO) Down 3.1% Since Last Earnings Report?
Are Investors Undervaluing Perrigo (PRGO) Right Now?
PRGO
Published: June 06, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Are Investors Undervaluing Perrigo (PRGO) Right Now?
Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
PRGO
Published: May 23, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN , May 23, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to present at the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference, being conducted virtually on Tuesday, June 10 at 9 AM ET. Interested parties can access the webcast on the Perrigo website at http://perrigo.investorroom.com/events-webcasts.

Read More
image for news Perrigo to Attend the Oppenheimer 25th Annual Consumer Growth & E-Commerce Conference
Wall Street Analysts Predict a 27.28% Upside in Perrigo (PRGO): Here's What You Should Know
PRGO
Published: May 22, 2025 by: Zacks Investment Research
Sentiment: Positive

The mean of analysts' price targets for Perrigo (PRGO) points to a 27.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Read More
image for news Wall Street Analysts Predict a 27.28% Upside in Perrigo (PRGO): Here's What You Should Know
Is Perrigo (PRGO) Stock Undervalued Right Now?
PRGO
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Read More
image for news Is Perrigo (PRGO) Stock Undervalued Right Now?
Perrigo (PRGO) Reliance on International Sales: What Investors Need to Know
PRGO
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive

Evaluate Perrigo's (PRGO) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Read More
image for news Perrigo (PRGO) Reliance on International Sales: What Investors Need to Know
Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y
PRGO
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral

PRGO reports mixed first-quarter 2025 results. The top line declines, largely due to the loss of sales stemming from exited businesses and product lines.

Read More
image for news Perrigo Q1 Earnings Beat Estimates, Revenues Decline Y/Y
Perrigo Company plc (PRGO) Q1 2025 Earnings Call Transcript
PRGO
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral

Perrigo Company plc (NYSE:PRGO ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Bradley Joseph - Vice President of Global Investor Relations Patrick Lockwood-Taylor - President & Chief Executive Officer Eduardo Bezerra - Chief Financial Officer Conference Call Participants Susan Anderson - Canaccord Genuity Keith Devas - Jefferies Daniel Biolsi - Hedgeye Operator Good morning, ladies and gentlemen and welcome to the Perrigo Q1 2025 Financial Results Conference Call. At this time, all lines are in listen-only mode.

Read More
image for news Perrigo Company plc (PRGO) Q1 2025 Earnings Call Transcript
Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
PRGO
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral

While the top- and bottom-line numbers for Perrigo (PRGO) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More
image for news Perrigo (PRGO) Reports Q1 Earnings: What Key Metrics Have to Say
Perrigo (PRGO) Q1 Earnings Beat Estimates
PRGO
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive

Perrigo (PRGO) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.29 per share a year ago.

Read More
image for news Perrigo (PRGO) Q1 Earnings Beat Estimates
Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations
PRGO
Published: May 07, 2025 by: PRNewsWire
Sentiment: Neutral

Advancing 'Three-S' Plan to Stabilize, Streamline and Strengthen Perrigo, which was Detailed at February 2025 Investor Day Delivered Strong First Quarter 2025 Adjusted EPS Growth and Margin Expansion, Driven by Infant Formula and OTC Brands Widened 2025 Net Sales Target Ranges, Due Primarily to Macroeconomic Uncertainty; Reaffirmed All Other Previously Provided 2025 Financial Targets, Including Adj. EPS Range DUBLIN , May 7, 2025 /PRNewswire/ -- First Quarter 2025 Highlights: Net sales of $1.04 billion declined 3.5%, due primarily to an unfavorable impact of 3.2% from divested businesses, exited product lines and currency translation.

Read More
image for news Perrigo Reports First Quarter 2025 Financial Results From Continuing Operations
Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock?
PRGO
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative

PRGO's first-quarter top line is likely to have been impacted by exited businesses and product lines, and unfavorable currency movements.

Read More
image for news Perrigo to Report Q1 Earnings: Is a Beat in Store for the Stock?
Perrigo Announces Quarterly Dividend
PRGO
Published: April 30, 2025 by: PRNewsWire
Sentiment: Neutral

DUBLIN , April 30, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.290 per share, payable on June 17, 2025, to shareholders of record on May 30, 2025. About Perrigo Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Read More
image for news Perrigo Announces Quarterly Dividend
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
PRGO
Published: April 21, 2025 by: Benzinga
Sentiment: Negative

J.P. Morgan say s Perrigo Company plc's PRGO first-quarter 2025 earnings will be dominated by commentary on the potential impact of tariffs. The analyst says, “Tariffs could potentially have a significant impact on PRGO's near-term earnings.

Read More
image for news Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan

About Perrigo Company plc (PRGO)

  • IPO Date 1991-12-17
  • Website https://www.perrigo.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Patrick Lockwood-Taylor
  • Employees 8379

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.